comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 16:26:04 - browse：4183

A photograph of someone preparing small petri dishes, each holding several 1-7 day old embryos, for cells to be extracted from each embryo to test for viability at an in vitro fertilization lab — In vitro fertilization lab staff prepare small petri dishes, each holding embryos. (This sample image doesn't necessarily show embryos grown in media from CooperSurgical, a supply giant now facing lawsuits.) Michael Wyke/AP

Patients from all over the country are filing lawsuits against medical supply giant CooperSurgical, alleging that fluid the company sent to in vitro fertilization clinics destroyed their embryos.

The fluid, called culture media, is filled with nutrients that allow embryos to develop enough to ultimately be implanted into a uterus. CooperSurgical acknowledged that the batch of fluid may have stunted embryo growth in a product recall notice, but it hasn’t disclosed exactly what went wrong. Lawsuits claim the media lacked magnesium, a key nutrient, while a Cooper representative told STAT the cause is still under investigation.

The recall could be a one-off manufacturing fluke. But the debacle, and the uncertainty around the problems with the fluid, sheds light on a larger problem: IVF doctors rarely know the exact composition of culture media in the first place. The Food and Drug Administration asks manufacturers for a list of materials before the media goes on the market, an FDA spokesperson told STAT. Companies will sometimes give clinics this information voluntarily, along with required labeling information like mouse embryo data, instructions for use, and warnings. But the FDA doesn’t require companies to list the ingredients or their proportions publicly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： SCOTUS questions limit to govt efforts to fight misinformation

focus

WSS

Plastic surgeons increase patient psychiatric screenings

Intermittent fasting comes with a heart risk? Not so fast

Protect nursing home residents from future pandemics

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

The world needs the new pandemic treaty

Unmasking the 'centricity' illusion in clinical trials

leisure time

comprehensive

Wikipedia

State Dept. review finds Biden bears some blame for Afghanistan failures

Asbestos, a deadly carcinogen, banned by EPA

Trump demands the U.S. pay no more for drugs than other countries … again

Should insurance cover cosmetic surgery?

The high cost of giving birth even with insurance

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Drug repurposing or repositioning? The language matters

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Peter Hotez and the public health issue of online harassment

Neuroscience’s long legacy of racism

focus

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Positive childhood experiences can help future health

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Guardant Health colon cancer test endorsed by FDA advisory panel

5 to watch: Tech startups trying to solve health care's staffing crisis

CVS Caremark has created a new ploy: the drug ‘rebate credit’

explore

focus

entertainment

focus